A - EEA & CIS PHARMA VENTURES

A - EEA & CIS PHARMA VENTURES is an investment fund structure domiciled in NICOSIA, Cyprus. Funds hold LEIs in their own right, and GLEIF records who manages them rather than who owns them.

The LEI has been on record for 6 years, since 16 Apr 2020. That puts it right on the median for Cyprus, where half of all LEIs date from before 2020.

Annual re-validation is 551 days overdue: it fell due 16 Mar 2025. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.